Matinas BioPharma Holdings, Inc.

MTNB · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2-$5-$2-$8
Dep. & Amort.$0-$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$0-$1$0
Other Non-Cash$0$4-$0$4
Operating Cash Flow-$1-$2-$2-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$1
Financing Activities
Debt Repay.$0-$0-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$2$2$0
Financing Cash Flow$0$2$2-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$1-$0-$0-$3
Supplemental Information
Beg. Cash$7$7$8$11
End Cash$6$7$7$8
Free Cash Flow-$1-$2-$2-$4
Matinas BioPharma Holdings, Inc. (MTNB) Financial Statements & Key Stats | AlphaPilot